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Abstract 
 Electrokinetic supercharging (EKS) is known as one of the most effective online 
electrophoretic preconcentration techniques, though pairing with it with mass spectrometry has 
presented challenges. Here, EKS is successfully paired with ESI-MS/MS to provide a sensitive and 
robust method for analysis of biogenic amines in biological samples. Injection parameters including 
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investigated to achieve suitable resolution, high sensitivity, and compatibility with ESI-MS. Using 
EKS, the sensitivity of the method was improved 5,000-fold compared to a conventional 
hydrodynamic injection (HDI) with capillary zone electrophoresis (CZE). The separation allowed for 
baseline resolution of several neurotransmitters within 16 min with limits of detection down to 10 pM. 
This method was applied to targeted analysis of seven biogenic amines from rat brain stem and whole 
Drosophila tissue. This is the first method to use EKS with CE-ESI-MS/MS to analyze biological 
samples.  
 




CE has become a popular technique for analysis of complex biological mixtures due to its fast 
and efficient separations as well as its small sample volume requirements [1–3]. A limitation for CE, 
until recently, was the difficulty of hyphenation with MS. The advent of robust and commercially 
available electrospray ionization (ESI) interfaces for CE-MS has opened many new uses in fields such 
as proteomics [4], food science [5], drug analysis [6], and genomics [7]. Recently, CE-MS has also 
gained momentum in metabolomics and neuroscience because of its ability to efficiently analyze 
many compounds simultaneously from small volumes of complex samples [4, 8, 9]. 
Currently two types of CE-MS interfaces are commonly used: sheath-flow and sheathless 
[10]. Sheathflow interfaces utilize coaxial conduits to add solvent and gas flow to assist with ESI. In 
contrast, sheathless interfaces generate stable ESI or nESI directly from the separation capillary to 
minimize dilution. Though sheathless methods are more difficult to achieve and operate routinely, 
they can still be robust and provide reasonable detection limits. For example, in a quantitative 
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were reported for several amino acids and metabolite compounds [11]. These LODs are relatively 
high compared to other separation and detection methods because of the small volumes injected into 
the capillary. Preconcentration methods are needed to allow lower detection limits and higher 
sensitivity by CE-MS. 
A variety of on-line preconcentration techniques have been developed to improve the 
detection sensitivity for CE, including field amplification sample stacking (FASS), field amplification 
sample injection (FASI), transient isotachophoresis (tITP), pH-mediated stacking, large volume 
sample stacking (LVSS), and sweeping [12, 13]. Many of these techniques have been reportedly used 
with CE-MS in order to achieve acceptable limits of detection, including FASI, dynamic pH junction, 
LVSS, and more [14–18]. Among the preconcentration techniques available for CE, electrokinetic 
supercharging (EKS) is one of the most powerful, as it can achieve more than 5 orders of magnitude 
improvement in detection sensitivity over conventional injections [19]. EKS combines FASI and tITP. 
This approach overcomes the limits on FASI, wherein a limited amount of sample can be injected 
before excessive band broadening reduces separation quality, by using tITP to re-concentrate such 
bands. Since its introduction in 2003 [20], EKS has been combined with UV absorbance detection to 
measure low abundance analytes such as rare earth metals [21], environmental contaminants [22], 
protein complexes [23], DNA [24], peptides [25], and drugs [26]. 
To perform EKS, a small plug of high ionic strength leading electrolyte (LE) is loaded into 
the separation capillary, followed by a small plug of water. A long electrokinetic injection (EKI) is 
then performed. During this step, FASI occurs, where charged analytes preferentially enter the 
capillary and then reduce migration rate as they contact the relatively low electric field in the LE 
zone.  A final small plug of low ionic strength terminating electrolyte (TE) is loaded and the 
separation voltage is applied. Here tITP occurs, where the fast LE and slow TE cause a gradient of the 
electric field across the sample zone, allowing the analytes to further concentrate into distinct zones. 
As the zones progress, the LE and TE eventually dissipate and a CZE separation occurs in the 
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desirable to limit the movement of the stacking boundary into the capillary during injection by using 
counter-flow or reduced electroosmotic flow [21–24]. 
Little work has been reported on interfacing EKS to CE-MS. This is due to several key 
challenges, including obtaining proper buffer compatibility, controlling flow, and maintaining a 
robust ground at the ESI interface. Pairing with MS requires volatile buffers that will be acceptable 
for ESI without ionization suppression. Choosing MS compatible buffers limits the number of buffer 
options available, which is an important selection in EKS for achieving a compatible LE and ionic 
strength requirements for stacking. Using counter-flow to suppress analyte migration down the 
capillary is not easily implemented with MS detection, where the capillary outlet is interfaced to an 
ionization source. Without the option of counter-flow, reducing migration during injection is largely 
dependent on buffer composition. For example, if a low pH buffer is used for EKS it will reduce the 
EOF, allowing for a longer injection without losing effective capillary length for subsequent tITP; but, 
reduced EOF comes at the cost of reduced separation speed and/or efficiency. Finally, maintaining a 
robust ground for stable separation current during EKS with CE-MS is challenging. The grounded 
sheath liquid is responsible for grounding the separation and producing stable electrospray ionization; 
but, concentrated zones of ions generated from EKS can interfere with grounding and ESI stability. 
The interface requires careful selection of sheath liquid composition and its flow rates throughout a 
separation, as well as a reliable assembly of the interface. 
One use of EKS with CE-MS has been reported [27]. This pioneering method achieved 
baseline resolution analysis of five hypolipidemic drugs with 1000-fold improvements in detection 
sensitivity over conventional injections. Though drastically lowering detection limits for these drugs, 
this method required regular disassembly of the CE-MS interface for capillary treatments with EOF 
reversal agents as well as an applied pressure during separation to produce and maintain a reversed 
EOF system necessary to analyze the desired anionic compounds. Such steps compromise robustness, 
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In this work, we describe a new approach to EKS that is compatible with CE-MS. The 
method provides an online system by using a buffer that permits normal (cathodic) but suppressed 
EOF, allowing for sensitive and efficient analysis without regular capillary treatment or pretreatment 
of aqueous samples as previously reported. Suppressing EOF allows for longer FASI injections and 
subsequently lower LODs in this method. The preconcentration allows for a 5000-fold improvement 
in detection limits compared to CZE with HDI. This EKS-MS achieves LODs down to 10 pM in a 16-
min separation for seven biogenic amine neurotransmitters.  
As a demonstration, the method is applied to determination of several neurotransmitters 
(Table S1) in tissue sample extracts. Previous work has reported EKS-CE-UV analysis of low 
abundance neurotransmitters [28, 29];  however, the steps required to achieve sufficient LODs, 
namely counterflow to achieve longer injections, made the methods incompatible with MS detection, 
hence limiting the number of possible analytes and selectivity of detection. Measuring neurochemical 
concentrations can provide important insights into pathological states, pharmacological treatments, 
and brain functions [30]. Biogenic amines are implicated in many different diseases/dysfunctions and 
drug therapies, including Parkinson’s Disease [31], Alzheimer’s Disease [32], and depression [33]. 
Studying changes in the composition of the brain and the amine-based neurochemicals can lead to 
better understanding of these systems and diseases. Analyzing neurochemicals from tissue samples 
demonstrates the utility of the method to quantify low concentration compounds from limited sample 
volume.  
 
2 Materials and Methods 
2.1 Reagents and Materials 
All chemicals and solvents were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless 
stated otherwise. Formic acid (99%) was from Acros Organics (Geel, Belgium). Stable-isotope 
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standards and internal standards were prepared in HPLC-grade water as 100 µM and 100 nM stocks 
(respectively), aliquoted, and stored at -80 ⁰ C. The standard and internal standard aliquots were 
thawed daily (single use) and diluted for use. Standard mixes consisted of the seven neurotransmitters 
of interest and internal standard mixes of deuterated versions of the compounds of interest, excluding 
tyramine and octopamine. BGE contained 50 mM ammonium formate (pH 2.5) and 40% MeOH (v/v) 
and LE contained 250 mM ammonium formate (pH 2.5). Buffers were prepared fresh twice weekly, 
adjusting the pH by formic acid, sonicating for 10 min, and filtering through 0.45 µm membrane 
filter. Sheath-flow buffer contained 5 mM ammonium formate and 50% MeOH (v/v).  
2.2 Instrumentation 
Electrophoretic separations were performed on an Agilent 7100 Capillary Electrophoresis 
System using Agilent Masshunter software for CE-MS and Agilent ChemStation software for CE-UV. 
Electrophoresis experiments were performed in 80 cm of 50 µm inner diameter (id) and 360 µm outer 
diameter (od) fused silica capillaries coated with polyimide from Polymicro Technologies (Phoenix, 
AZ, USA). New capillaries were treated by flushing the capillary with 1 M NaOH for 20 min, HPLC-
grade water for 5 min, and BGE for 10 min. ESI was carried out using an Agilent CE ESI-MS Sprayer 
and an Agilent 1260 Infinity Isocratic Pump to control the sheath-flow. MS detection was performed 
on an Agilent 6410 Triple Quadrupole, using Agilent Masshunter software. 
2.2.1 HDI 
The capillary was filled with BGE. A short plug of HPLC-grade water was introduced at the 
inlet at 50 mbar for 1 s. Sample was injected at 50 mbar for 65 s to fill 5% of the capillary volume. A 
separation of 30 kV was applied.  
2.2.2 EKS 
The capillary was filled with BGE, and a plug of LE was injected at 50 mbar for 30 s. A plug 
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then injected electrokinetically at 30 kV (375 V/cm) for 150 s. A separation voltage of 30 kV was 
applied. 
2.2.3 FASI 
The capillary was filled with BGE. A short plug of HPLC-Grade water was hydrodynamically 
introduced at the inlet at 50 mbar for 1 s. Sample was then injected electrokinetically at 30 kV (375 
V/cm) for 30 s, (injections ranged from 5 – 50 s for comparisons). A separation voltage of 30 kV was 
applied.  
2.2.4 FASS 
The capillary was filled with BGE. A short plug of HPLC-Grade water was hydrodynamically 
introduced at the inlet at 50 mbar for 1 s. Sample was then injected hydrodynamically at 50 mbar for 
195 s to fill 15% of the capillary volume (injections filling 5 – 25% capillary volume tested for 
comparisons). A separation voltage of 30 kV (375 V/cm) was applied. 
2.2.5 ESI-MS 
For ESI, sheath liquid flow rate was set to 10 µL/min and nebulizer gas flow at 12 psi. Drying 
gas was used to assist with desolvation with a flow rate of 8 L/min at 300 C. The electrospray 
potential was set to 4 kV. For MS, multiple reaction monitoring (MRM) mode was used to enhance 
specificity. Precursor ions were selected in quadrupole one and product ions in quadrupole three for 
each compound (Table S1) and collision energies were optimized to produce the highest abundance of 
each product ion with dwell times of 200 ms. The source and drying gas temperature was 250 ⁰ C. 
2.3 Sample Preparation 
2.3.1 Rat Brain Stem 
Homogenate was prepared from a whole rat brain stored at -80 ⁰ C. After thawing, the brain 
stem was sliced off and homogenized using a pestle homogenizer in a vial with cold ACN (10 
µL/mg). The homogenate was centrifuged 13 x 10
3




This article is protected by copyright. All rights reserved. 
 
The supernatant was dried with nitrogen and resuspended in water (10x original volume). The sample 
was then aliquoted (100 µL aliquots) into vials which were subsequently frozen and stored at -80 ⁰ C 
until analysis. After thawing, 1% internal standard (v/v) was added prior to analysis.  
2.3.2 Whole Fly 
Homogenate was prepared by homogenizing 10 whole Drosophila (male) in 150 µL of cold 
ACN, centrifuging, and removing the supernatant. Aliquots were stored at -80 ⁰ C until day of 
analysis. After thawing, 1% internal standard (v/v) was added and they were dried with nitrogen and 
resuspended in water (same volume) for immediate analysis.  
2.3.3 LC-MS/MS Analysis 
Chromatographic separations were conducted using a Waters nanoAcquity UPLC using a 1.0 
x 100 mm column with HSS T3 1.8 µm particles interfaced to a mass spectrometer. Mobile phase A 
and B consisted of 5 mM ammonium formate with 0.15% formic acid and neat ACN, respectively. 
The gradient ran from 5% to 19% B in 0.01 min, 19% to 26% in 0.67 min, 26% to 75% B in 0.375 
min, 75% to 100% B in 0.75 min, and stayed at 100% B for 0.1 min. The flow rate was set at 0.6 
mL/min. 
For LC-MS analysis of the brain stem homogenate supernatant (as prepared above, excluding 
internal standard addition), a benzoylation reaction was implemented [34]. Derivatization involved 
mixing 2 volumes of sample (aqueous supernatant) with 1 volume of 100 mM sodium carbonate to 
raise the pH. Then 1 volume of 2% (v/v) benzoyl chloride in ACN was added followed by 1 volume 
of internal standard in 1% sulfuric acid (v/v) in 20/80 MeOH/water. The resulting mixture was 
analyzed by LC-MS. The internal standard mixture is comprised of analyte standards derivatized with 
the same procedure using C
13
 benzoyl chloride as the derivatizing agent. 
3 Results and Discussion 
 We sought to develop an EKS method that was compatible with CE-MS. The approach 
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of MS/MS detection. The method is demonstrated to be suitable for analysis of tissue extracts for 
selected neurochemicals. 
Initial experiments were performed with UV detection and a subset of our test compounds 
including dopamine (DA), epinephrine (EPI), norepinephrine (NE), and serotonin (5HT). These 
experiments focused on using low pH electrophoresis buffers to both facilitate analyte ionization 
during electrospray ionization and to suppress EOF [35]. Suppressing the EOF is required to allow for 
a long EKI without excessive migration down the capillary which would limit resolving power for 
positively charged analytes. 20 mM ammonium formate at pH 2.5 was initially selected due to its 
buffer capacity at low pH and compatibility with ESI. Aqueous ammonium formate did not allow for 
baseline resolution of all four compounds. To further lower EOF and improve selectivity, methanol 
was added to the buffer and the ammonium formate concentration of the water/methanol solution was 
increased to 50 mM to maintain comparable conductivity to buffer without methanol (Figure 1A). The 
final buffer chosen consisted of 50 mM ammonium formate in water/MeOH (60:40 v/v) with pH 2.5. 
This buffer offers a low EOF, which will allow for longer injections during preconcentration without 
diminishing resolution. 
Using the above electrophoresis buffer and samples consisting of standards dissolved in 
water, it was possible to use FASI. Under these conditions FASI is limited to < 30 s injection before 
peak broadening and tailing becomes apparent and affects resolution (See Figure S1).  Peak tailing is 
a limitation of FASI here, as it reduces achievable resolution. Utilizing a leading electrolyte and 
terminating electrolyte to achieve EKS can allow longer injections. LE buffer was chosen by testing 
the electrolytes sodium chloride and ammonium formate. 250 mM ammonium formate, pH 2.5, 
showed the best results as a LE, nearly double the peak signal than with 100 mM NaCl (See Figure 
1B). Additionally, ammonium formate is more compatible than NaCl for MS due to its volatility. A 
30 s injection at 50 mbar was used for LE loading, filling the capillary 2.3% to obtain a sufficient LE 
zone without drastically affecting the separation current.  
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Use of 5 mM taurine (50 mbar, 10 s) loaded as a TE improved peak widths as expected for 
tITP. For example, a 15 s injection at 30 kV without a loaded TE gave DA peak width of 10.4 s, while 
the same injection and separation with a short plug of 5 mM taurine as a terminator loaded post-
injection provided a peak width of 5.4 s (Figure 2A).  
Interestingly however, we also observed that if TE was omitted, peaks became narrower and 
taller as injection time increased (Figure 2B). Intentional addition of a TE did not improve injections 
at these long times. We hypothesize that this result is due to a system-induced terminating electrolyte 
[21]. System-induced terminating electrolyte formation is a previously reported phenomenon which 
can result in tITP behavior such as that seen here [36, 37]. All further work used 30 kV, 150 s 
injections with no added TE.  
We tested the method on 7 analytes. Applying the LE and TE parameters determined above, 
at a separation voltage of 30 kV using an 80 cm capillary with 150 s 30 kV injection, 5 of the 7 
analytes were baseline resolved in a 16-min separation with LODs down to 10 pM using MS detection 
(Figure S2). 
 3.2 EKS vs. Other injection Methods 
To determine the effectiveness of the EKS method, we compared it to a conventional HDI, FASI, and 
FASS (Table 1) (LODs reported in table 1 are improved in this comparison over LODs determined 
from calibration standards due to increased scan rate in the MS/MS detection, reducing the LOD to 10 
pM in this comparison for DA). HDI is a commonly used mode of sample loading in CZE. It is useful 
for injecting all the analytes present without bias for the higher mobility compounds, though the 
maximum injection volume is limited due to peak broadening at larger capillary occupancy. 
Generally, injection volumes occupying over 5% of the capillary volume can lead to detrimental 
effects on the efficiency of an electrophoretic separation [38]. As shown in table 1, we observed a 
5000-fold enhancement in the detection limits in EKS compared to HDI, and substantial 
enhancements over FASI and FASS. EKS offers the lowest limits of detection compared to the other 
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While EKS maintains relatively Gaussian peak shapes, FASI and FASS have apparent broadening and 
display peak tailing, which can be detrimental to separation efficiency and resolution. 
 3.3 Application to Biological Samples 
The limits of detection determined for the compounds makes this method potentially suitable for 
detecting trace compounds. Calibrations showed linearity (R
2
 = 0.99) from a 0.1 – 100 nM range of 
concentrations for most compounds and LODs from 30 – 140 pM (Table S2). To demonstrate the 
utility of the method to determine several neurochemicals in tissue samples, the method was applied 
to both rat brain tissue and whole Drosophila tissue. Supernatant from a rat brain stem homogenate 
was analyzed and all seven neurochemicals in the method were quantified from triplicate injections 
(Figure 4). To successfully determine these chemicals, a 10-fold dilution of the supernatant in water 
was necessary to avoid the negative effects of the sample matrix on the stacking. Figure 4A shows the 
concentrations after accounting for the 10-fold dilution, reflecting the original concentrations in the 
tissue extract. In Figure 4B, each trace shows the detection of one of the seven analytes from the brain 
tissue. Choline (Ch) overloads and interacts with capillary surface at high concentrations resulting in 
poor peak shape; however, this effect did not affect linearity of calibration (see Table S2). 
Supernatant of whole Drosophila homogenate was also analyzed to measure the 
neurotransmitters in a sample that contains lower concentrations. Figure S3 shows the four 
neurochemicals and their concentrations in the supernatant. The concentrations correspond to an 
average of 0.17, 26, 0.010 and 0.046 pmol/fly of DA, Ch, octopamine (OA) and 5HT, respectively. 
All seven analytes could not be detected as EPI and NE are not present in flies, and tyramine (TyrA) 
was below the LOD in this analysis. In this tissue Ch, DA, 5HT and OA were able to be quantified 
with good repeatability, with RSD ranging from 4.8% – 17.3%. In this analysis, the method 
demonstrated its ability to simultaneously measure pM (OA) and µM (Ch) concentrations, as well as 
the range between. 
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To verify the concentrations quantified by the EKS method, the same rat brain homogenate 
supernatant was analyzed using a published LC-MS/MS method [39]. Shown in Figure 4A, the 
concentrations determined by LC-MS/MS were comparable to the values determined by EKS, where 
concentrations determined differed by 14% – 46% between the two methods. Catecholamines DA, 
Epi, and NE differed between the two methods by 37%, 40% and -20% respectively. Catecholamine 
analogues TyrA and OA differed by 44 and -45% respectively and indolamine 5HT by 45%. Ch 
differed by 14%. Choline, the only compound without oxidizable moieties, had the most similar 
measured concentration between the methods.  
A possible source of the difference in results between CE-MS and LC-MS methods is sample 
stability [40]. For CE-MS, samples were kept at room temperature for ~4 h before analysis. In 
contrast, for LC-MS samples were derivatized immediately before analysis. Derivatization has 
previously been shown to stabilize many of the oxidation prone neurotransmitters such as 
catecholamines and indoleamines [39]. All compounds but OA and NE were measured to be higher 
concentrations by LC-MS, and OA and NE are within error of concentrations determined by each 
method. To test if sample stability contributes to error between methods, rat brain homogenate 
supernatant was analyzed by LC-MS after sitting at room temperature for up to 4 h before 
derivatization (Figure S4). DA, NE, Epi, and 5HT saw loss of concentrations by 20%, 11%, 24%, and 
3.5%, respectively between 0 hours (n = 5) and 4 hours (n = 4). This loss of concentration for several 
of the analytes accounts for a substantial portion of error seen in between the methods. Other potential 
sources of error include differences in the sample treatment and separation parameters for each 
method. These results suggest that more rapid analysis or more care taken in preventing oxidation 
may be important in increasing the accuracy of the CE-MS method. Though all sources of the 
differences between these two methods is not completely understood, this comparison proves the 
utility of the presented method, showing comparable accuracy to existing methods. Being a CE-based 
method, this can inject from and uses less sample volume than LC-based methods, making it 
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information that cannot be obtained by LC-MS, due to its orthogonality as a separation method, i.e., 
resolution of isomers OA and DA (Figure 4B). 
4 Concluding Remarks 
 A sensitive EKS method has been developed that can successfully interface to CE-MS. This 
method overcomes many challenges and previous limitations of pairing this method of 
preconcentration to MS through careful selection of buffer systems and positively charged analytes 
that can be analyzed by the method. LODs in this system are sufficient to analyze small molecules in 
many different samples, with detection limits down to 10 pM concentrations from standards, showing 
5000-fold enhancements in detection sensitivity over conventional injections. This method has been 
applied to biogenic amine neurotransmitters from tissue samples. In principle the method could be 
applied to other tissues. Improvements in protection against oxidation would be required for better 
accuracy. Samples containing high ionic strength matrices such as microdialysate and plasma can also 
be measured in this method, however they would require a pretreatment to remove or exchange the 
sample matrix prior to EKS.  
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Figure Legends 
Figure 1. (A) Effect of buffer on CE separation of 1 µM DA, 5HT, EPI, and NE at 20 kV in 60 cm 
long capillary. Increasing ionic strength and methanol allow for increased selectivity to resolve 
overlapping peaks in the original separation. (B) Comparison of 200 mM ammonium formate and 100 
mM sodium chloride as LE during a tITP injection. Analytes 1 µM DA, E, and NE dissolved in water. 
Separation was performed at 20 kV in a 60 cm capillary using the previously chosen background 
electrolyte. Ammonium formate LE offers increased peak height and decreased broadness 
 
Figure 2: (A) Shows the comparison of a 15 s injection with and without a loaded terminating 
electrolyte (5 mM taurine). Substantial peak broadening and loss of resolution can be seen without a 
TE loaded after the injection, indicating a loss of tITP. (B) This figure shows the EKS method with 
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gained and the peaks become narrower, indication the formation of a system-induced TE and 
subsequent tITP at longer injection durations. 
 
Figure 3. Comparison of EKS method with conventional HDI injection and other common forms of 
preconcentration in CE-MS. Concentrations of standards chosen to fit well within dynamic range for 
each method. For all, EKS background electrolyte was used with 30 kV separation voltage in an 80 
cm capillary. Leading electrolyte only used in the EKS method. FASI performed at 30 kV for 30 s and 
EKS injection performed at 30 kV for 150 s. HDI and FASS injections performed using 50 mbar to 
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Figure 4: (A) Quantification of compounds in the rat brain stem. Concentrations determined by LC-
MS/MS assay used for verification (grey bars). Each EKS injection used 100 µL of sample and LC 
injections used 5 µL of sample per injection. Measurements were made from three different aliquots 
of a single brain stem homogenate supernatant for each method. The error bars represent the standard 
deviation in each method determined for each compound from triplicate measurements. (B) Extracted 
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Table 1. The developed EKS method compared to other forms of injection and preconcentration. 
LODs, resolution, and peak width are compared for each method. Enhancement factor is the quotient 
of a method’s LOD over the LOD from HDI 
Method LOD (nM)a Enhancement FWHM (s) Res 
HDIb 50 - 4.7 1.09 
FASSc 20 2.5 9.6 0.37 
FASI (30 s) 0.07 7.1 x 102 5.5 0.95 
EKS (150 s) 0.01 5 x 103 4.2 1.02 
a
LODs approximated using S/N = 3        
b
HDI loads 5% of capillary volume 
c
FASS fills 15% of capillary volume 
 
